Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation

Blood (2024) 143 (10): 872–881.

https://doi.org/10.1182/blood.2023022281

Published: 2024

Includes: Supplemental data

Journal Articles

Transient Monosomy 7 Is a Rare Event in Young Children with SAMD9L Syndrome

Blood (2022) 140 (Supplement 1): 8678–8679.

https://doi.org/10.1182/blood-2022-159221

Published: 2022

Journal Articles

Hypersensitivity Reactions to Native E. coli L-Asparaginase in Children with Acute Lymphoblastic Leukemia May Vary By Treatment Schedule and Type of Glucocorticoid in Induction: Results of Trial ALL-BFM 2000

Blood (2022) 140 (Supplement 1): 11676–11678.

https://doi.org/10.1182/blood-2022-163142

Published: 2022

Journal Articles

Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

Blood (2022) 140 (14): 1635–1649.

https://doi.org/10.1182/blood.2022015506

Published: 2022

Includes: Supplemental data

Journal Articles

Reduced Intensity Delayed Intensification in Standard-Risk Patients Defined By Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia: Results of an International Randomized Trial in 1164 Patients (Trial AIEOP-BFM ALL 2000)

Martin Schrappe, MD, Martin Zimmermann, PhD, Anja Möricke, MD, Georg Mann, MD, Maria Grazia Valsecchi, PhD, Claus R. Bartram, PhD, Andrea Biondi, MD, Renate Panzer-Grümayer, MD, Rita Beier, MD, Gunnar Cario, Franco Locatelli, MD, Giuseppe Basso, Felix Niggli, MD, Maurizio Aricò, MD, Valentino Conter

Blood (2016) 128 (22): 4.

https://doi.org/10.1182/blood.V128.22.4.4

Published: 2016

Journal Articles

Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience

Blood (2016) 128 (3): 440–448.

https://doi.org/10.1182/blood-2016-03-704015

Published: 2016

Journal Articles

The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis

Blood (2016) 127 (25): 3281–3290.

https://doi.org/10.1182/blood-2015-12-684498

Published: 2016

Includes: Supplemental data

Journal Articles

Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000

Blood (2016) 127 (17): 2101–2112.

https://doi.org/10.1182/blood-2015-09-670729

Published: 2016

Includes: Supplemental data

Journal Articles

Response-Adapted Sequential Immuno-Chemotherapy of Post-Transplant Lymphoproliferative Disorders in Pediatric Solid Organ Transplant Recipients: Results from the Prospective Ped-PTLD 2005 Trial

Britta Maecker-Kolhoff, MD, Rita Beier, MD, Martin Zimmermann, PhD, Brigitte Schlegelberger, MD, Ulrich Baumann, MD, Carsten Mueller, MD, Lars Pape, MD, Alfred Reiter, MD, Claudia Rossig, MD, Stephan Schubert, MD, Burkhard Toenshoff, MD, Anne-Margret Wingen, MD, Barbara Meissner, MD, Christian Kebelmann-Betzing, MD, Guenter Henze, MD, Hans H. Kreipe, MD, Christoph Klein, MD PhD

Blood (2014) 124 (21): 4468.

https://doi.org/10.1182/blood.V124.21.4468.4468

Published: 2014

Journal Articles

Hodgkin’s Disease / Hodgkin-PTLD after Solid Organ Transplantation in Children: A Report on 16 Patients Treated According to Subsequent Gpoh-HD Treatment Schedules

Johanna Kampers, Rita Beier, MD, Manuela A. Orjuela-Grimm, MD ScM, Tilmann Schober, MD, Thomas Schulz, MD, Martina Stiefel, MD, Christoph Klein, MD PhD, Christine Mauz-Koerholz, MD, Hans H. Kreipe, MD, Britta Maecker-Kolhoff, MD

Blood (2014) 124 (21): 1612.

https://doi.org/10.1182/blood.V124.21.1612.1612

Published: 2014

Journal Articles

Pediatric Fanconi Anemia With Secondary AML: A Retrospective Outcome Report From The German AML-BFM Group

Rita Beier, MD, Sayed Hoseini, MD, Britta Maecker-Kolhoff, MD, Reinhard Schneppenheim, MD, PhD, Christine von Neuhoff, MD, Wolfram Ebell, MD, Hansjörg Schmid, MD, Peter Bader, Karoline Ehlert, MD, Karl-Walter Sykora, MD, Ursula Creutzig, MD, Christian Kratz, Mwe Mwe Chao, MD, Dirk Reinhardt, Martin G. Sauer, MD

Blood (2013) 122 (21): 1414.

https://doi.org/10.1182/blood.V122.21.1414.1414

Published: 2013

Journal Articles

Hematopoietic Stem Cell Gene Therapy For Wiskott- Aldrich Syndrome

Blood (2013) 122 (21): 718.

https://doi.org/10.1182/blood.V122.21.718.718

Published: 2013

Journal Articles

Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)

Blood (2012) 119 (25): 6016–6024.

https://doi.org/10.1182/blood-2011-12-398958

Published: 2012

Includes: Supplemental data

Journal Articles

The phenotype of human STK4 deficiency

Hengameh Abdollahpour, Giridharan Appaswamy, Daniel Kotlarz, Jana Diestelhorst, Rita Beier, Alejandro A. Schäffer, E. Michael Gertz, Axel Schambach, Hans H. Kreipe, Dietmar Pfeifer, Karin R. Engelhardt, Nima Rezaei, Bodo Grimbacher, Sabine Lohrmann, Roya Sherkat, Christoph Klein

Blood (2012) 119 (15): 3450–3457.

https://doi.org/10.1182/blood-2011-09-378158

Published: 2012

Includes: Supplemental data

Journal Articles

G6PC3 Deficiency Associated with Congenital Neutropenia and Enterocolitis

Jana Diestelhorst, Daniel Kotlarz, Giridharan Appaswamy, PhD, Rita Beier, MD, Peter M Krawitz, MD, PhD, Peter N Robinson, MD, PhD, Jochen Hecht, PhD, Jacek Puchalka, PhD, Alejandro A. Schäffer, PhD, Dietmar Pfeifer, PhD, Ulrich Baumann, MD, Eva-Doreen Pfister, MD, Gudrun Brandes, PhD, Gabriella Palla, MD, Roland Jacobs, PhD, Hans H. Kreipe, MD, Stefan Mundlos, MD, Christoph Klein, MD, PhD

Blood (2011) 118 (21): 2170.

https://doi.org/10.1182/blood.V118.21.2170.2170

Published: 2011

Journal Articles

The Phenotype of Human STK4 Deficiency

Hengameh Abdollahpour, MD, PhD, Giridharan Appaswamy, PhD, Rita Beier, MD, Alejandro A. Schäffer, PhD, E. Michael Gertz, PhD, Hans H. Kreipe, MD, Dietmar Pfeifer, PhD, Bodo Grimbacher, MD, Sabine Lohrmann, MD, Roya Sherkat, MD, Christoph Klein, MD, PhD

Blood (2011) 118 (21): 692.

https://doi.org/10.1182/blood.V118.21.692.692

Published: 2011

Journal Articles

Efficacy of Gene Therapy for Wiskott-Aldrich-Syndrome

Blood (2011) 118 (21): 165.

https://doi.org/10.1182/blood.V118.21.165.165

Published: 2011

Journal Articles

Successful Allogeneic Hematopoietic Stem Cell Transplantation for Severe Inflammatory Bowel Disease – IL10 Receptor Deficiency May Serve as a Novel Therapeutic Paradigm

Rita Beier, Daniel Kotlarz, Kaan Boztug, Erik Glocker, Eva Doreen Pfister, Jana Diestelhorst, Dhaarini Murugan, Ulrich Baumann, Sibylle Koletzko, Axel Sauerbrey, Stephan Bruderus, Bodo Grimbacher, Martin G. Sauer, MD, Karl-Walter Sykora, Christoph Klein

Blood (2010) 116 (21): 2379.

https://doi.org/10.1182/blood.V116.21.2379.2379

Published: 2010

Journal Articles

Correction of Wiskott-Aldrich Syndrome by Hematopoietic Stem Cell Gene Therapy

Blood (2010) 116 (21): 5.

https://doi.org/10.1182/blood.V116.21.5.5

Published: 2010

Journal Articles

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

Blood (2010) 115 (16): 3206–3214.

https://doi.org/10.1182/blood-2009-10-248146

Published: 2010

Includes: Supplemental data

NARROW

Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation

Transient Monosomy 7 Is a Rare Event in Young Children with SAMD9L Syndrome

Hypersensitivity Reactions to Native E. coli L-Asparaginase in Children with Acute Lymphoblastic Leukemia May Vary By Treatment Schedule and Type of Glucocorticoid in Induction: Results of Trial ALL-BFM 2000

Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

Reduced Intensity Delayed Intensification in Standard-Risk Patients Defined By Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia: Results of an International Randomized Trial in 1164 Patients (Trial AIEOP-BFM ALL 2000)

Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience

The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis

Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000

Response-Adapted Sequential Immuno-Chemotherapy of Post-Transplant Lymphoproliferative Disorders in Pediatric Solid Organ Transplant Recipients: Results from the Prospective Ped-PTLD 2005 Trial

Hodgkin’s Disease / Hodgkin-PTLD after Solid Organ Transplantation in Children: A Report on 16 Patients Treated According to Subsequent Gpoh-HD Treatment Schedules

Pediatric Fanconi Anemia With Secondary AML: A Retrospective Outcome Report From The German AML-BFM Group

Hematopoietic Stem Cell Gene Therapy For Wiskott- Aldrich Syndrome

Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)

The phenotype of human STK4 deficiency

G6PC3 Deficiency Associated with Congenital Neutropenia and Enterocolitis

The Phenotype of Human STK4 Deficiency

Efficacy of Gene Therapy for Wiskott-Aldrich-Syndrome

Successful Allogeneic Hematopoietic Stem Cell Transplantation for Severe Inflammatory Bowel Disease – IL10 Receptor Deficiency May Serve as a Novel Therapeutic Paradigm

Correction of Wiskott-Aldrich Syndrome by Hematopoietic Stem Cell Gene Therapy

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only